Developer of robotic endoscopic technology for natural orifice transluminal endoscopic surgery (NOTES). The company develops robotic endoscopic technology for the emerging area of Natural Orifice Transluminal Endoscopic Surgery (NOTES) and technology designed to revolutionize the way physicians visualize and deliver therapies within the body.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Merger/Acquisition | 01-Jun-2009 | 000.00 | Completed | Generating Revenue | ||
6. Debt - General | 13-Nov-2008 | 00.000 | 000.00 | Completed | Generating Revenue | |
5. Later Stage VC (Series C) | 21-Sep-2006 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
4. Bridge | 07-Feb-2006 | 000 | 000.00 | Completed | Generating Revenue | |
3. Early Stage VC (Series B) | 22-Jun-2005 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
2. Early Stage VC (Series B) | 12-Dec-2003 | $14M | $17.2M | Completed | Startup | |
1. Early Stage VC (Series A) | 13-Jun-2002 | $3.25M | $3.25M | 00.000 | Completed | Product Development |
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.00 |
Series B | 00,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
Series A | 3,570,000 | $0.001000 | $0.08 | $0.4 | $1 | 2x | $0.4 | 3.05% |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-2009507617-A | Method and apparatus for performing transluminal and other operations | Granted | 14-Sep-2005 | 00000000000 | |
US-20070135803-A1 | Methods and apparatus for performing transluminal and other procedures | Abandoned | 14-Sep-2005 | 00000000000 | 00 |
JP-2010069314-A | Apparatus for performing transluminal and other procedures | Withdrawn | 14-Sep-2005 | 00000000000 | |
EP-1931237-A2 | Methods and apparatus for performing transluminal and other procedures | Withdrawn | 14-Sep-2005 | 00000000000 | |
US-20060235457-A1 | Instruments having a rigidizable external working channel | Abandoned | 15-Apr-2005 | A61M25/0032 | 00 |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Amir Belson MD | Co-Founder, Chief Technology Officer, President & Board Member |
Name | Representing | Role | Since |
---|---|---|---|
Amir Belson MD | Self | Co-Founder, Chief Technology Officer, President & Board Member | 000 0000 |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
3i Group | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Advent Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
Arboretum Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
DC Capital Partners | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Kaiser Permanente Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |